2019-2027 NGS-Based RNA-Seq Market Trends and 19.3% of Prime CAGR Growth Lead by Pacific Biosciences of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, BGI, Oxford Nanopore Technologies, Perkinelmer

NGS based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome.

The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.

NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002556

The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period

Key Players Influencing in the NGS-Based RNA-Seq Market-
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

The objective of the study is to describe, define, and forecast the NGS based RNA seq market by product & services, technology, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPBT00002556

The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.

The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.

The NGS based RNA seq market report analyzes factors affecting NGS based RNA seq market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, , opportunities, and future trend. The report provides the analysis for the every segment in detail across all the regions such as North America, Europe, Asia Pacific, Middle East & Africa and South and Central America.

Buy this Report at https://www.theinsightpartners.com/buy/TIPBT00002556

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.